m+Medelevator.RU
← Поиск публикаций
Oral diseases · 2026

Exosomes of Porphyromonas gingivalis-Infected Macrophages Impair the Endothelial Barrier and Angiogenesis In Vitro.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zhou Yanling, Huang Yihua, Lv Xiaomin, Liang Ailin, Liu Wenxuan, Tong Zhongchun, Gong Qimei

Аннотация

OBJECTIVES: Endothelial dysfunction is a key contributor to periodontal disease and apical periodontitis. However, the role of macrophages in mediating endothelial function via exosomes in these inflammatory diseases remains elusive.

MATERIALS AND METHODS: Exosomes isolated from Porphyromonas gingivalis (P.g)-infected THP-1-derived macrophages (P.g-Exos) and uninfected macrophages (Con-Exos) were verified and their effects on human umbilical vein endothelial cells (HUVECs) were investigated. The expression of TNF-α and IL-6 in HUVECs was tested by quantitative real time PCR (qRT-PCR) and ELISA. A fluorescein isothiocyanate (FITC)-dextran leakage assay and a THP-1 monocyte adhesion assay were used to explore vascular permeability and cellular adhesion. The migration and angiogenic capacity were evaluated using transwell, cell scratch, and tube-forming assays. HUVECs were pretreated with SC79 (Akt activator) to explore the mechanism.

RESULTS: P.g stimulation increased the release of exosomes from macrophages. P.g-Exos inhibited HUVECs' migration and tube formation capabilities while increasing vascular permeability, promoting leukocyte adhesion and releasing proinflammatory factors. Importantly, P.g-Exos induced endothelial dysfunction partially via the Akt/mTOR pathway suppression.

CONCLUSIONS: Summarily, this study reveals that the exosomes derived from inflammatory macrophages mediate HUVECs dysfunction partially via the Akt/mTOR pathway, providing novel insights into potential treatments for oral inflammatory diseases.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты